https://scholars.lib.ntu.edu.tw/handle/123456789/589660
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | CHI-YUAN YAO | en_US |
dc.contributor.author | Chen, Ching-Hsuan | en_US |
dc.contributor.author | HUAI-HSUAN HUANG | en_US |
dc.contributor.author | HSIN-AN HOU | en_US |
dc.contributor.author | CHIEN-CHIN LIN | en_US |
dc.contributor.author | Tseng, Mei-Hsuan | en_US |
dc.contributor.author | Kao, Chein-Jun | en_US |
dc.contributor.author | TZU-PIN LU | en_US |
dc.contributor.author | WEN-CHIEN CHOU | en_US |
dc.contributor.author | HWEI-FANG TIEN | en_US |
dc.date.accessioned | 2021-12-07T03:17:04Z | - |
dc.date.available | 2021-12-07T03:17:04Z | - |
dc.date.issued | 2017-08-22 | - |
dc.identifier.issn | 2473-9529 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/589660 | - |
dc.description.abstract | Long noncoding RNAs (lncRNAs) not only participate in normal hematopoiesis but also contribute to the pathogenesis of acute leukemia. However, their clinical and prognostic relevance in myelodysplastic syndromes (MDSs) remains unclear to date. In this study, we profiled lncRNA expressions in 176 adult patients with primary MDS, and identified 4 lncRNAs whose expression levels were significantly associated with overall survival (OS). We then constructed a risk-scoring system with the weighted sum of these 4 lncRNAs. Higher lncRNA scores were associated with higher marrow blast percentages, higher-risk subtypes of MDSs (based on both the Revised International Prognostic Scoring System [IPSS-R] and World Health Organization classification), complex cytogenetic changes, and mutations in RUNX1, ASXL1, TP53, SRSF2, and ZRSR2, whereas they were inversely correlated with SF3B1 mutation. Patients with higher lncRNA scores had a significantly shorter OS and a higher 5-year leukemic transformation rate compared with those with lower scores. The prognostic significance of our 4-lncRNA risk score could be validated in an independent MDS cohort. In multivariate analysis, higher lncRNA scores remained an independent unfavorable risk factor for OS (relative risk, 4.783; P < .001) irrespective of age, cytogenetics, IPSS-R, and gene mutations. To our knowledge, this is the first report to provide a lncRNA platform for risk stratification of MDS patients. In conclusion, our integrated 4-lncRNA risk-scoring system is correlated with distinctive clinical and biological features in MDS patients, and serves as an independent prognostic factor for survival and leukemic transformation. This concise yet powerful lncRNA-based scoring system holds the potential to improve the current risk stratification of MDS patients. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Blood advances | en_US |
dc.title | A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1182/bloodadvances.2017008284 | - |
dc.identifier.pmid | 29296792 | - |
dc.identifier.scopus | 2-s2.0-85066616446 | - |
dc.identifier.url | https://scholars.lib.ntu.edu.tw/handle/123456789/548760 | - |
dc.relation.journalvolume | 1 | en_US |
dc.relation.journalissue | 19 | en_US |
dc.relation.pageend | 1516 | en_US |
item.openairetype | journal article | - |
item.fulltext | no fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Laboratory Medicine-NTUH | - |
crisitem.author.dept | Laboratory Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Laboratory Medicine | - |
crisitem.author.dept | Laboratory Medicine-NTUH | - |
crisitem.author.dept | Institute of Health Data Analytics and Statistics | - |
crisitem.author.dept | Public Health | - |
crisitem.author.dept | Laboratory Medicine | - |
crisitem.author.dept | Laboratory Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.orcid | 0000-0001-5052-9445 | - |
crisitem.author.orcid | 0000-0003-2780-4845 | - |
crisitem.author.orcid | 0000-0001-7160-2285 | - |
crisitem.author.orcid | 0000-0003-3697-0386 | - |
crisitem.author.orcid | 0000-0003-2967-698X | - |
crisitem.author.orcid | 0000-0002-1384-5593 | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Public Health | - |
crisitem.author.parentorg | College of Public Health | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。